149 related articles for article (PubMed ID: 34542816)
21. Long Noncoding RNA HNF1A-AS1 Regulates Osteosarcoma Advancement Through Modulating the miR-32-5p/HMGB1 Axis.
Lou P; Ding T; Zhan X
Cancer Biother Radiopharm; 2021 May; 36(4):371-381. PubMed ID: 32706998
[No Abstract] [Full Text] [Related]
22. LncRNA CCDC144NL-AS1 Serves as a Prognosis Biomarker for Non-small Cell Lung Cancer and Promotes Cellular Function by Targeting miR-490-3p.
Zhang L; Chi B; Chai J; Qin L; Zhang G; Hua P; Jin C
Mol Biotechnol; 2021 Oct; 63(10):933-940. PubMed ID: 34115289
[TBL] [Abstract][Full Text] [Related]
23. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
Jiang Z; Jiang C; Fang J
Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989
[TBL] [Abstract][Full Text] [Related]
24. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression.
Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022
[TBL] [Abstract][Full Text] [Related]
25. LncRNA ODRUL regulates progression of osteosarcoma by regulating IL-6 via sponging miR-6874-3p.
Zhan T; Zhu K; Hu J; Ma X; Zhu Y; Zhang C
Exp Cell Res; 2022 Mar; 412(2):113050. PubMed ID: 35114192
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.
Zhang X; Zhao X; Li Y; Zhou Y; Zhang Z
J Cell Physiol; 2019 Aug; 234(10):17494-17504. PubMed ID: 30912129
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma.
Wang Y; Zeng X; Wang N; Zhao W; Zhang X; Teng S; Zhang Y; Lu Z
Mol Cancer; 2018 May; 17(1):89. PubMed ID: 29753317
[TBL] [Abstract][Full Text] [Related]
28. SP1-mediated upregulation of lncRNA LMCD1-AS1 functions a ceRNA for miR-106b-5p to facilitate osteosarcoma progression.
He JW; Li DJ; Zhou JH; Zhu YL; Yu BQ
Biochem Biophys Res Commun; 2020 Jun; 526(3):670-677. PubMed ID: 32248969
[TBL] [Abstract][Full Text] [Related]
29. [Lnc-TMEM132D-AS1 overexpression reduces sensitivity of non-small cell lung cancer cells to osimertinib].
Zhao Q; Wang N; Li Y; Wu Q; Wu L
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Feb; 43(2):242-250. PubMed ID: 36946044
[TBL] [Abstract][Full Text] [Related]
30. LncRNA CBR3-AS1 predicts unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
Zhang Y; Meng W; Cui H
Biomed Pharmacother; 2018 Jun; 102():169-174. PubMed ID: 29554595
[TBL] [Abstract][Full Text] [Related]
31. LncRNA WAC-AS1 promotes osteosarcoma Metastasis and stemness by sponging miR-5047 to upregulate SOX2.
Yang Z; Liu Z; Lu W; Guo H; Chen J; Zhang Y
Biol Direct; 2023 Nov; 18(1):74. PubMed ID: 37957698
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma.
Ye H; Lin J; Yao X; Li Y; Lin X; Lu H
Cell Physiol Biochem; 2018; 45(5):1904-1914. PubMed ID: 29518771
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of long non-coding RNA HOST2 expression and its tumor-promotive function in human osteosarcoma.
Qi XD; Xu SY; Song Y
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):921-927. PubMed ID: 29509239
[TBL] [Abstract][Full Text] [Related]
34. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
35. High levels of long non-coding RNA DICER1-AS1 are associated with poor clinical prognosis in patients with osteosarcoma.
Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7640-7645. PubMed ID: 30536305
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of lncRNA SNHG12 reversed IGF1R-induced osteosarcoma metastasis and proliferation by targeting miR-195-5p.
Xu N; Xu J; Zuo Z; Liu Y; Yan F; Han C
Gene; 2020 Feb; 726():144145. PubMed ID: 31743769
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/β-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9).
Zhang H; Liu S; Tang L; Ge J; Lu X
Bioengineered; 2021 Dec; 12(1):162-171. PubMed ID: 33356805
[TBL] [Abstract][Full Text] [Related]
38. Linc00460 promotes osteosarcoma progression via miR-1224-5p/FADS1 axis.
Lian H; Xie P; Yin N; Zhang J; Zhang X; Li J; Zhang C
Life Sci; 2019 Sep; 233():116757. PubMed ID: 31419446
[TBL] [Abstract][Full Text] [Related]
39. MiR-455-3p downregulation facilitates cell proliferation and invasion and predicts poor prognosis of osteosarcoma.
Yi X; Wang Y; Xu S
J Orthop Surg Res; 2020 Oct; 15(1):454. PubMed ID: 33008443
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA ADIRF antisense RNA 1 upregulates insulin receptor substrate 1 to decrease the aggressiveness of osteosarcoma by sponging microRNA-761.
Xu L; Tan Y; Xu F; Zhang Y
Bioengineered; 2022 Feb; 13(2):2028-2043. PubMed ID: 35030964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
